About Alphatec Holdings, Inc. 
Alphatec Holdings, Inc.
Pharmaceuticals & Biotechnology
Alphatec Holdings, Inc. is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. Its products include Cervical and Cervico-Thoracic Products, which include Trestle Luxe Anterior Cervical Plate System and Pegasus Anchored Cervical Interbody; Thoracolumbar Fixation Products, which include Arsenal Degenerative System and OsseoScrew Spinal Fixation System; Spinal Spacers, which include Battalion Universal Spacer System and Alphatec Solus Locking ALIF Spinal Spacer; minimally invasive surgery Products, which include Illico Minimally Invasive Surgery System and BridgePoint Spinous Process Fixation System, and Biologics, which include Neocore Osteoconductive Matrix.
Company Coordinates 
Company Details
5818 El Camino Real , CARLSBAD CA : 92008
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 61 Schemes (22.61%)
Foreign Institutions
Held by 95 Foreign Institutions (10.21%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Patrick Miles
Chairman of the Board, President, Chief Executive Officer
Mr. Mortimer Berkowitz
Lead Independent Director
David Pelizzon
Director
Mr. Jeffrey Rydin
Director
Mr. Evan Bakst
Independent Director
Mr. Quentin Blackford
Independent Director
Revenue and Profits:
Net Sales:
186 Million
(Quarterly Results - Jun 2025)
Net Profit:
-41 Million
Pharmaceuticals & Biotechnology
USD 2,448 Million (Small Cap)
NA (Loss Making)
NA
0.00%
8.51
-272.15%
51.67






